Skip to main content

Audiometric and Surgical Outcomes of a Novel Bone-Conduction Hearing Aid.

Publication ,  Journal Article
Quimby, AE; Park, J; Brant, JA; Eliades, SJ; Kaufman, HS; Bigelow, DC; Ruckenstein, MJ
Published in: Otol Neurotol
October 1, 2022

OBJECTIVE: To report the audiometric and surgical outcomes of a series of patients having undergone implantation of a novel transcutaneous bone conduction implant (t-BCI). STUDY DESIGN: Retrospective case series. SETTING: Single academic tertiary referral center. PATIENTS: Adults (≥18 yr) implanted between December 1, 2019, and August 1, 2021, with audiometric data available before and after device implantation and a minimum of 4 weeks follow-up. INTERVENTIONS: Surgical t-BCI. MAIN OUTCOME MEASURES: Change in aided pure tone average (PTA) after implantation. Secondary outcomes include average operative time, and adverse events. RESULTS: Twenty-three patients underwent implantation of the t-BCI via either a conventional or minimally invasive surgical approach. The most common indication for implantation was unilateral conductive hearing loss with a history of chronic otitis media. The mean operative time was 59 minutes. The mean preimplantation unaided air conduction PTA was 65 dB, and mean postimplantation was 27.2 dB. The mean change in PTA was 37.8 dB, which was significant ( p < 0.0001). There were 30.4% of the patients that suffered from adverse events, the most common of which were pain (8.7%) and device-related complications (13%). One major adverse event occurred, involving magnet displacement that impaired device activation and required reoperation for replacement. CONCLUSION: Forming the largest series of patients implanted with this t-BCI in the published literature, our data demonstrate that implantation of the device is feasible via either a traditional or minimally invasive surgical approach, with good audiometric benefit and a favorable safety profile.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Otol Neurotol

DOI

EISSN

1537-4505

Publication Date

October 1, 2022

Volume

43

Issue

9

Start / End Page

995 / 999

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Otorhinolaryngology
  • Humans
  • Hearing Loss, Conductive
  • Hearing Aids
  • Bone Conduction
  • Adult
  • 4201 Allied health and rehabilitation science
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Quimby, A. E., Park, J., Brant, J. A., Eliades, S. J., Kaufman, H. S., Bigelow, D. C., & Ruckenstein, M. J. (2022). Audiometric and Surgical Outcomes of a Novel Bone-Conduction Hearing Aid. Otol Neurotol, 43(9), 995–999. https://doi.org/10.1097/MAO.0000000000003668
Quimby, Alexandra E., Jino Park, Jason A. Brant, Steven J. Eliades, Hannah S. Kaufman, Douglas C. Bigelow, and Michael J. Ruckenstein. “Audiometric and Surgical Outcomes of a Novel Bone-Conduction Hearing Aid.Otol Neurotol 43, no. 9 (October 1, 2022): 995–99. https://doi.org/10.1097/MAO.0000000000003668.
Quimby AE, Park J, Brant JA, Eliades SJ, Kaufman HS, Bigelow DC, et al. Audiometric and Surgical Outcomes of a Novel Bone-Conduction Hearing Aid. Otol Neurotol. 2022 Oct 1;43(9):995–9.
Quimby, Alexandra E., et al. “Audiometric and Surgical Outcomes of a Novel Bone-Conduction Hearing Aid.Otol Neurotol, vol. 43, no. 9, Oct. 2022, pp. 995–99. Pubmed, doi:10.1097/MAO.0000000000003668.
Quimby AE, Park J, Brant JA, Eliades SJ, Kaufman HS, Bigelow DC, Ruckenstein MJ. Audiometric and Surgical Outcomes of a Novel Bone-Conduction Hearing Aid. Otol Neurotol. 2022 Oct 1;43(9):995–999.

Published In

Otol Neurotol

DOI

EISSN

1537-4505

Publication Date

October 1, 2022

Volume

43

Issue

9

Start / End Page

995 / 999

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Otorhinolaryngology
  • Humans
  • Hearing Loss, Conductive
  • Hearing Aids
  • Bone Conduction
  • Adult
  • 4201 Allied health and rehabilitation science
  • 3202 Clinical sciences